Home > Healthcare > Analytical Instruments > Molecular Analysis > Bioprocess Analyzers Market

Bioprocess Analyzers Market Size

  • Report ID: GMI8765
  • Published Date: Mar 2024
  • Report Format: PDF

Bioprocess Analyzers Market Size

Bioprocess Analyzers Market size was valued at around USD 2.1 billion in 2023 and is estimated to grow at 15.2% CAGR from 2024 to 2032. Bioprocess analyzers are specialized instruments used in biotechnology and pharmaceutical industries to monitor and analyze various parameters related to biological processes occurring in bioreactors and fermentation systems. These analyzers are essential tools for ensuring product quality and maintaining control over critical parameters. The advancements in biotechnology and bioprocessing are significant driving factors for the market.

 

For instance, according to Elsevier’s report, in 2024, process analytical technology analyzers could measure physical and chemical process factors and key attributes with the goal of optimizing process controls. This technology, in the form of a probe or sensor, is designed to integrate within the pharmaceutical manufacturing line and is coupled with computing equipment to perform chemometric modeling for result interpretation and multilayer statistical control of processes. Thus, helping in optimizing yields by providing accurate data on cell growth, metabolite production, and substrate utilization.
 

Furthermore, growing demand for biopharmaceutical products, increasing demand for biosimilar (market size is estimated to account for USD 122.9 billion by the end of year 2032), rising government initiatives and funding, surge in biologics outsourcing, are the contributing factors stimulating the growth of the market.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The Global bioprocess analyzers industry was valued at around USD 2.1 billion in 2023 and is estimated to reach over USD 6.9 billion by 2032, driven by advancements in biotechnology and bioprocessing, along with surge in biologics outsourcing.

Consumables & accessories segment held a decent market share in 2023 and is estimated to account for USD 3.9 billion by 2032, as these items are consumed regularly during bioprocess monitoring, necessitating frequent replenishment.

North America bioprocess analyzers market accounted for USD 831.4 million in 2023 and is predicted to witness substantial growth through 2032, driven by a well-established and thriving biopharmaceutical sector in the region.

Agilent Technologies, Inc., Algenax, Danaher Corporation, F. Hoffmann-La Roche Ltd, Groton Biosystems LLC, Kaiser Optical Systems, Inc., Nova Biomedical, Randox Laboratories Ltd., Sartorius AG, SYSBIOTECH GmbH, Thermo Fisher Scientific Inc. are some of the major industry contenders.

Bioprocess Analyzers Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 272
  • Countries covered: 22
  • Pages: 150
 Download Free Sample